Komal Jhaveri

Komal Jhaveri is a breast oncologist specializing in precision oncology and early-phase clinical trials, including experience treating patients with secretory breast carcinoma harboring ETV6-NTRK3 fusions using NTRK inhibitors such as larotrectinib and entrectinib. She has contributed to case series and retrospective analyses of NTRK inhibitor responses in rare breast cancer histologies and advocates for molecular profiling of rare subtypes. She also investigates novel ADC and PI3K inhibitor combinations in advanced breast cancer.